research , page-14

Get your hand off it, monkey66. A valuation of 49 cents is just as ludicrous as .49 cents.

As PortableAlpha so eloquently said, NDL is going nowhere fast. A valuation in the 10 - 15 cents range seems appropriate, but there are no near-term price catalysts to move it up or down. Trial results are more than a year away, yet some success has already been factored into the market value - and this is a real worry. A correction of 15 - 20% to the downside seems likely.